Alison Stopeck, MD | Stony Brook Cancer ...

Dr. Alison Stopeck, MD

Claim this profile

Stony Brook University Cancer Center

Studies Breast Cancer
Studies Chemotherapy
5 reported clinical trials
8 drugs studied

Area of expertise

1

Breast Cancer

Alison Stopeck, MD has run 5 trials for Breast Cancer. Some of their research focus areas include:

Stage III
Stage II
HER2 negative
2

Chemotherapy

Alison Stopeck, MD has run 1 trial for Chemotherapy. Some of their research focus areas include:

Stage III

Affiliated Hospitals

Image of trial facility.

Stony Brook University Cancer Center

Image of trial facility.

Stony Brook Breast Center

Clinical Trials Alison Stopeck, MD is currently running

Image of trial facility.

DNA-Guided Adjuvant Therapy

for Breast Cancer

A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive, HER-2 negative breast cancer (DARE)

Recruiting

1 award

Phase 2

9 criteria

Image of trial facility.

Contrast-Enhanced Mammography

for Breast Cancer

The purpose of this study is to compare a special type of mammogram that uses a contrast agent called contrast-enhanced digital mammography with contrast-enhanced digital breast tomosynthesis (CEDM+CEDBT), with breast magnetic resonance imaging imaging (MRI) for predicting the effect of neoadjuvant chemotherapy on pathologic complete response rates. The device used to obtain CEDM+CEDBT images is called Siemens MAMMOMAT. This device produces two-dimensional (2D) images, as in a normal mammogram, but also collects additional images for digital breast tomosynthesis (DBT), which produces a three-dimensional (3D) image of the breast in the form of image slices. DBT allows the radiologist to "see through" the breast tissue for better detection and localization of breast cancer. By looking at both the CEDM images and the CEDBT images, a radiologist may be able to better detect residual breast cancer in a more cost-effective manner. Participation may last up to 18 weeks. Study procedures for this research are: * Undergoing 1-2 mammograms during and/or after your chemotherapy, but before primary breast surgery. * Before each mammogram, have a radiology technician inject a liquid contrast agent by inserting a needle into a vein. The chemotherapy port cannot be used to receive the contrast agent * Let the research team record information from your medical record related to your condition and the treatment you receive. * Give permission to collect leftover tissue from your diagnostic biopsy and breast surgery.

Recruiting

1 award

Phase < 1

More about Alison Stopeck, MD

Clinical Trial Related

5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Alison Stopeck, MD has experience with

  • Placebo
  • Omnipaque 350mgI/mL Solution For Injection
  • Fulvestrant
  • Palbociclib
  • Denosumab
  • Sulindac Pill

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Alison Stopeck, MD specialize in?

Is Alison Stopeck, MD currently recruiting for clinical trials?

Are there any treatments that Alison Stopeck, MD has studied deeply?

What is the best way to schedule an appointment with Alison Stopeck, MD?

What is the office address of Alison Stopeck, MD?

Is there any support for travel costs?